Some @entity1 with @entity384 who are inotrope dependent but remain well by undergoing infusions can be managed by ambulatory infusions at home. We report our results in 20 @entity1 awaiting heart transplantation, unable to be weaned from intravenous inotropic therapy on 2 or more occasions, but who were well while receiving inotropes and received home ambulatory infusions. The @entity1 were treated with @entity1289 inhibitors, digoxin, diuretics, vasodilators, close electrolyte management, and low-dose @entity2643 for those with more than four-beat @entity1165 . Infusions were delivered by a tunneled subclavian catheter and syringe driver. Thirteen @entity1 received @entity935 , four received @entity452 , and three received both. Mean duration of inotropic therapy was 5 months with 70% of the time spent as an outpatient. Eleven @entity1 received transplants, two remain on the waiting list, and seven died after being removed from the list because of general @entity8 . There were no sudden @entity204 . Actuarial survival was 71% at 3 months, which is not less than that expected for an inotrope-dependent population. All @entity1 with @entity1000 survived to transplantation. In contrast, all three with @entity712 caused by @entity358 and four of seven with @entity296 died. Inpatient days were reduced by 70%, leading to considerable cost savings. Home ambulatory inotropic therapy is safe, cost-effective, best suited to those with @entity1000 , and dramatically reduces inpatient hospital duration.

Continuous home ambulatory intravenous inotropic drug therapy in severe XXXX : safety and cost efficacy.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2643 :: ('MESH:D000638', 'Chemical') :: ['amiodarone'] @entity8 :: ('MESH:D007674', 'Disease') :: ['deterioration or renal dysfunction'] @entity1165 :: ('MESH:D017180', 'Disease') :: ['ventricular tachycardia'] @entity1289 :: ('1636', 'Gene') :: ['ACE'] @entity452 :: ('MESH:D004280', 'Chemical') :: ['dobutamine'] @entity712 :: ('MESH:D006333', 'Disease') :: ['right heart failure'] @entity935 :: ('MESH:D004298', 'Chemical') :: ['dopamine'] @entity384 :: ('MESH:D002311', 'Disease') :: ['dilated cardiomyopathy'] @entity296 :: ('MESH:D009202', 'Disease') :: ['ischemic cardiomyopathy'] @entity1000 :: ('MESH:C536277', 'Disease') :: ['idiopathic dilated cardiomyopathy'] @entity358 :: ('MESH:D008171', 'Disease') :: ['pulmonary vascular disease'] @entity204 :: ('MESH:D003643', 'Disease') :: ['deaths']
@entity712 :: (MESH:D006333,Disease) :: ['heart failure']
